Eleftha Injection (440mg)
Eleftha Injection (440mg), which contains Trastuzumab, is a targeted therapy used primarily in the treatment of certain types of breast cancer and gastric cancer that overexpress the HER2 protein. This medication is designed to inhibit the growth of cancer cells by binding to the HER2 receptor, thereby blocking the signals that promote tumor growth. Eleftha Injection is typically administered intravenously and is often used in conjunction with other chemotherapy agents to enhance its effectiveness. The composition of Eleftha includes Trastuzumab as the active ingredient, which is a monoclonal antibody that specifically targets HER2-positive cancer cells. This innovative treatment option has revolutionized the management of HER2-positive cancers, providing patients with a more effective and personalized approach to their therapy.
Essential Drug Facts
| Dosage form | Iv(Intravenous) Injection |
|---|---|
| Habit Forming | No |
| Systemic Category | Oncology |
What are the Indication / Medical Uses of Eleftha Injection (440mg)
Eleftha Injection (440mg) is indicated for the treatment of patients with HER2-positive breast cancer, either in the early stages or metastatic forms, as well as for HER2-positive gastric or gastroesophageal junction adenocarcinoma. It is often prescribed for patients who have not received prior anti-HER2 therapy or chemotherapy for their metastatic disease. The drug is also used in combination with other chemotherapy agents to improve overall treatment outcomes and is an essential component of the therapeutic regimen for patients with these specific cancer types.
How Does Eleftha Injection (440mg) Benefit You?
The benefits of Eleftha Injection (440mg) for patients include its ability to specifically target and inhibit the growth of HER2-positive cancer cells, leading to improved survival rates and better quality of life. By blocking the HER2 receptor, Eleftha can slow down or stop the progression of cancer, making it a vital option for patients diagnosed with HER2-positive breast or gastric cancers. Additionally, the use of Eleftha in combination with other treatments can enhance the overall effectiveness of cancer therapy, providing patients with a more comprehensive approach to their treatment.
.svg)
Eleftha Injection (440mg) Action Mechanism
Eleftha Injection (440mg) works by binding to the HER2 receptor on the surface of cancer cells, preventing the receptor from receiving growth signals. This action inhibits the proliferation of cancer cells and can lead to their destruction. The drug also triggers immune responses that help the body fight against the cancer. By specifically targeting HER2-positive cells, Eleftha minimizes damage to normal cells, which is a significant advantage over traditional chemotherapy that can affect both cancerous and healthy cells.
How should Eleftha Injection (440mg) be used
To use Eleftha Injection (440mg) properly, it is essential to follow the dosage instructions provided by a healthcare professional. The medication is typically administered intravenously, and the dosage may vary based on the patient's body weight and the specific treatment regimen. It is crucial to receive Eleftha in a clinical setting under the supervision of a qualified healthcare provider to monitor for any potential side effects and ensure the correct administration of the drug.
When is the best time to take Eleftha Injection (440mg) ?
The best time to take Eleftha Injection (440mg) is determined by the treatment plan established by the healthcare provider. It is usually given in cycles, with specific intervals between doses to allow the body to recover from any side effects. Patients should adhere to the schedule provided by their healthcare team to maximize the effectiveness of the treatment and minimize the risk of complications.
How does it affect me if I overdose?
In the event of an overdose of Eleftha Injection (440mg), patients may experience severe side effects, including increased risk of heart problems, severe allergic reactions, or other serious complications. It is crucial to seek immediate medical attention if an overdose is suspected, as prompt intervention can mitigate potential risks and manage adverse effects effectively.
.svg)
How does it affect me if I miss a dose?
If a dose of Eleftha Injection (440mg) is missed, it is important to contact a healthcare provider as soon as possible to determine the best course of action. Depending on the timing of the missed dose, the healthcare provider may recommend rescheduling the dose or adjusting the treatment plan. Missing a dose can potentially affect the overall effectiveness of the treatment, so timely communication with a healthcare professional is essential.
Drug Adverse Reactions of Eleftha Injection (440mg)
Possible side effects and adverse reactions of Eleftha Injection (440mg) may include fever, chills, nausea, vomiting, diarrhea, fatigue, and allergic reactions such as rash or difficulty breathing. Some patients may also experience heart-related issues, including decreased heart function. It is important for patients to report any unusual symptoms to their healthcare provider promptly to ensure appropriate management of side effects.
Eleftha Injection (440mg) Tablet is contraindicated in following conditions
Eleftha Injection (440mg) is contraindicated in patients with a known hypersensitivity to Trastuzumab or any of its components. Additionally, it should not be used in patients with severe heart problems or those who have experienced significant heart failure. A thorough medical history should be reviewed before initiating treatment to identify any potential contraindications.
Eleftha Injection (440mg) Safety Warnings and Precautions
While there are no direct contraindications, alcohol consumption may exacerbate side effects or interfere with treatment, so moderation is advised.
Patients with a known hypersensitivity to Trastuzumab or any of its components should avoid using this medication due to the risk of severe allergic reactions.
Trastuzumab may cause harm to the developing fetus, and its use during pregnancy is not recommended due to potential risks of birth defects and other complications.
The safety and efficacy of Trastuzumab in pediatric patients have not been established, and its use should be carefully considered by a healthcare provider.
It is not known whether Trastuzumab is excreted in human breast milk, and due to the potential for serious adverse effects in nursing infants, breastfeeding is generally not recommended during treatment.
While Trastuzumab is not known to impair driving ability directly, side effects such as fatigue or dizziness may affect a patient's ability to operate vehicles safely, so caution is advised.
Patients with renal impairment may require dose adjustments or closer monitoring, as kidney function can affect the clearance of the drug.
Patients with pre-existing lung conditions may be at increased risk for pulmonary complications, and any respiratory symptoms should be evaluated promptly.
Patients with liver impairment should be monitored closely, as liver function can influence the metabolism and excretion of Trastuzumab.
Trastuzumab can cause cardiotoxicity, particularly in patients with pre-existing heart conditions or those receiving other cardiotoxic therapies, necessitating careful cardiac monitoring.
Interactions between Eleftha Injection (440mg)
Eleftha Injection (440mg) may interact with other medications, potentially altering their effectiveness or increasing the risk of side effects. It is essential for patients to inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions. Some drugs that may interact with Eleftha include certain chemotherapy agents and medications that affect heart function.
How to store and dispose of Eleftha Injection (440mg)
To store Eleftha Injection (440mg) properly, it should be kept in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F) and protected from light. It is important not to freeze the medication. Any unused or expired medication should be disposed of according to local regulations, and patients should not throw it in the household trash. Instead, they should consult their pharmacist or healthcare provider for safe disposal methods.
Here are a few quick tips for Eleftha Injection (440mg)
Here are a few quick tips for using Eleftha Injection (440mg) effectively and safely: always follow your healthcare provider's instructions regarding dosage and administration; report any side effects or unusual symptoms immediately; keep all follow-up appointments for monitoring; maintain a healthy diet and hydration; and inform your healthcare provider of any other medications you are taking to avoid interactions.
Parameters that should be monitored Eleftha Injection (440mg)
While using Eleftha Injection (440mg), it is important to monitor specific parameters, including heart function, liver and kidney function, and any signs of allergic reactions. Regular blood tests may be required to assess the patient's overall health and response to treatment. Patients should also be vigilant for any new or worsening symptoms and report them to their healthcare provider promptly.
Considerations related to diet Eleftha Injection (440mg)
Dietary considerations while using Eleftha Injection (440mg) include maintaining a balanced diet rich in fruits, vegetables, and whole grains to support overall health. Patients should also stay well-hydrated and may need to avoid certain foods that could exacerbate side effects, such as those high in sugar or fat. Consulting with a nutritionist may be beneficial to create a personalized dietary plan during treatment.
Question and Answer (FAQ)
Q: What is Eleftha Injection used for?
A: Eleftha Injection is used to treat HER2-positive breast cancer and gastric cancer.
Q: How is Eleftha Injection administered?
A: Eleftha Injection is administered intravenously by a healthcare professional.
Q: What are the common side effects of Eleftha Injection?
A: Common side effects include fever, chills, nausea, vomiting, and fatigue.
Q: Can Eleftha Injection be used during pregnancy?
A: Eleftha Injection should be used with caution during pregnancy due to potential risks to the fetus.
Q: Is Eleftha Injection safe for breastfeeding mothers?
A: Breastfeeding mothers should use Eleftha Injection with caution, as it may be excreted in breast milk.
Q: What should I do if I miss a dose of Eleftha Injection?
A: If you miss a dose, contact your healthcare provider for guidance on rescheduling.
Q: Can Eleftha Injection interact with other medications?
A: Yes, Eleftha Injection may interact with other medications, so inform your healthcare provider of all drugs you are taking.
Q: How should Eleftha Injection be stored?
A: Store Eleftha Injection in a refrigerator and protect it from light.
Q: What precautions should I take while using Eleftha Injection?
A: Monitor for side effects, maintain follow-up appointments, and inform your healthcare provider of any other medications.
Q: Is Eleftha Injection suitable for children?
A: Eleftha Injection should be used with caution in children, as its safety and efficacy in this population are not well established.
Reviews
There are no reviews yet.